CyberKnife Treatment Cost in India
CyberKnife offers patients new hope for the treatment of tumors and lesions, including ones that have previously been diagnosed as inoperable or untreatable.
CyberKnife uses state-of-the-art, real time image guidance similar to the cruise missile technology, to precisely target tumors anywhere in the body with pinpoint accuracy and to deliver intense doses of radiation.
- CyberKnife is a radiation therapy used as non-invasive treatment for cancerous tumors anywhere in the body and cost of CyberKnife in India is USD 7000 to USD 8000.
- It delivers radiation directly to the cancerous tissue thus fewer side effects and higher success rates.
- It is an out-patient treatment and is undertaken in 1 to 6 sessions.
- Tests required for determining the size, shape and location of the tumor are CT Scan, MRI, Angiography and PET.
During Cyberknife radiosurgery procedure, the tumour receives a cumulative dose of radiation to control or destroy the tumour cells while radiation exposure to surrounding tissue is minimised. The Cyberknife is able to compensate for patient movement to ensure highly accurate delivery of radiation during treatment.
When patient movement occurs during treatment, the cameras detect the position change, and the robot is able to compensate for the movement by repositioning the LINAC before administering the radiation beam. This process of constantly correcting for beam replacement ensures accurate tumour targeting.
What makes CyberKnife so unique?
• Unrivalled accuracy: The CyberKnife system can treat moving tumours with pinpoint accuracy, which is unmatched by other radiosurgery systems. This is especially important when treating tumours that move with any body function (e.g., breathing).
• Unlimited flexibility and freedom: The CyberKnife system’s robotic manoeuvrability allows doctors to deliver highly individualised treatments. With a linear accelerator mounted on a flexible robotic arm, CyberKnife clinicians can select various angles targeting the tumour with a high dose of radiation from every conceivable angle.
• Real-time image guidance: The CyberKnife uses a very sophisticated 6D image guidance system to track and continually adjust treatment for any movement of the patient or tumour.
• Convenient: Depending on the type of tumour, patients need only one to five CyberKnife treatments, typically lasting less than an hour each, while other radiation systems require dozens of treatments spread over several weeks.
• Patient safety: Unlike other gantry based linear accelerators, the CyberKnife operates on a fully integrated closed loop system. Each function works in unison to ensure the safest possible patient experience.
How Cyberknife Treatment is Done?
- The patient is positioned on the table ensuring his/her comfort. The robot moves around carefully to deliver radiation to the selected part.
- At the same time, the VSI system takes the X-ray of the part being treated to provide real-time location and images. This increases the precision and accuracy of the treatment being delivered.
- The patient undergoes 1 to 5 sessions, depending upon the severity and location of the tumour. Each session may last approximately for 1 hour.
What happens Post Cyberknife?
- Most of the patients undergoing Cyberknife do not require any kind of observation. It is highly probable that the patient will not experience any side-effects, (although there may be some which vary with the severity and location of the tumour).
- Follow up will depend on the case, site, disease or history of previous treatments and also further treatments if required. Please speak to your doctor about booking your follow up appointment.
What are the benefits of Cyberknife?
- Improved patient outcomes through better and more accurate targeting of tumour lesions
- A painless treatment procedure that requires no anaesthesia
- The technology is non-invasive and involves no blood loss
- Minimum exposure of healthy tissues to the harmful radiations
- Does not require hospitalisation; patients can immediately return to daily activities
- No or minimal complications for patients post procedure
What are Risks of Cyberknife?
- Short-term side effects
- Nausea
- Fatigue
- Headache
Cyberknife Used for treating following Cancers,
Lung cancer
CyberKnife is useful in treatment in early stage Lung Cancers when it is limited to a small area and can be used as an alternative to Radical Surgery. CyberKnife is also useful in cases of Lung Metastasis or post primary therapy limited residual or recurrent disease, when it can be targeted by the CyberKnife machine, as assessed by your Oncologist. The benefit of CyberKnife lies in delivery of radical ablative dose that can control the disease in a totally non-invasive mode. It has special capabilities of tracking the tumour while respiration and thus can treat with minimal extra margins and thus decreasing the side effects very efficiently.
Head and Neck Cancer
CyberKnife can be used as boost to small critical area close to the eyes or other vital areas to decrease the dose going to the vital areas and subsequent side effects. CyberKnife is also indicated for post-primary therapy residual and recurrent disease or Neck node residual or Recurrent disease
Breast Cancer
Sometimes in localised early stage Breast Cancers, CyberKnife can be used as a very short course Radiotherapy that can just target the postoperative surgical site. It is although possible only in selected cases and only treating oncologist can take this decision based on all available records and stage of the patient. CyberKnife can also be used in metastatic cases where the disease has spread from the Breast to other organs like Lung, Brain, Bone or Liver and is still limited that is lesser in number (< 6) or small size (< 6 cm). It cannot be used if there is a gross widespread disease.
Brain cancer
CyberKnife is used as a boost, for post-op residual or recurrent cases in malignant gliomas/glioblastomas. Brain tumours that may form good indications for CyberKnife radiosurgery include neuromas arising from other nerves, pituitary adenomas, hemangioblastomas and meningiomas, hemangiopericytomas.
Prostate cancer
The challenge in treating prostate tumours with radiation is that the prostate moves unpredictably as air passes through the rectum and as the bladder empties and fills. The CyberKnife Robotic Radiosurgery System is able to overcome this challenge by continuously identifying the exact location of the prostate in real time during the treatment and making active corrections for any movement of the prostate throughout the course of the radiation delivery. During treatment, a patient lays still and breathes normally while the CyberKnife zeroes in on a moving target, the prostate, and irradiates it without harming the surrounding areas. As a result, the procedure is more comfortable for patients, radiation is delivered more accurately and treatments can be completed in three to five sittings.Currently the CyberKnife Radiosurgery System is most frequently used as a single modality for early
Currently, the CyberKnife Radiosurgery System is most frequently used as a single modality for early organ confined prostate cancers or in combination with external beam radiotherapy as a boost, in cases of advanced or intermediate stages of prostate cancer. Depending on the stage of the patient’s prostate cancer doctors will recommend a treatment plan that best fits the patient’s case.
Liver cancer
Treating liver cancer with radiation therapy is a challenge because liver tumours move with respiration. In addition the tissue surrounding the liver tumours is very sensitive and can be damaged easily. The CyberKnife Radiosurgery System is able to deliver very high doses of radiation to both primary (before or after a liver transplant or in conjunction with chemotherapy or other treatments) and metastatic liver tumours with extreme accuracy. Working in conjunction with the CyberKnife System is the Synchrony Respiratory Tracking System, which enables the radiation beam to track tumour movement in real time and allows patients to breathe normally during their treatment sessions. With the CyberKnife System, doctors can zero in on a moving target the liver tumour and irradiate it without harming the healthy surrounding tissue.
Cancerous tumours in spine
CyberKnife is a good option sparing normal spinal cord with more precision than most of the other radiation delivery techniques. For local therapy in spinal tumours, CyberKnife can deliver highly focused radiation-sparing the surrounding normal tissues to a much greater extent.
Non-cancerous tumours
CyberKnife is a good option for ablative dosages that can be used as a valid alternative to surgery. Like Gamma Knife, CyberKnife works on a delivery of very high ablative dosages in a single or small number of sessions with precisions equal to or even more than Conventional Gamma Knife procedure. It has benefits of being non-invasive and does not need anaesthesia or blood loss. Apart from being used as an alternative to surgery, CyberKnife is also indicated for post-op residual or recurrent cases. Also, it can be used as a boost to Conventional Radiation.
Get Expert Second Opinion
